GlassScriptPhysician profile
Desiderio Avila
NPI 1528399144
$1,980.37
in general payments reported to CMS, 2019-2025
16 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $415 · 2021: $387 · 2022: $228 · 2023: $338 · 2024: $88.24 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $636.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $418.39 | 2019-2023 | Titan |
| Astellas Pharma US INC | $392.92 | 2019-2024 | Myrbetriq |
| Sumitomo Pharma America, INC. | $269.93 | 2023-2025 | Gemtesa |
| Boston Scientific Corporation | $265.40 | 2019-2025 | Ams 700 Cxr Rte Kit, Ams 700 |
| Procept Biorobotics Corporation | $181.24 | 2022-2023 | Aquabeam Robotic System |
| Neotract INC. | $100.75 | 2020 | |
| Teleflex LLC | $78.84 | 2021 | |
| Intuitive Surgical, INC. | $57.45 | 2023 | |
| Caldera Medical, INC | $54.37 | 2021-2023 | Desara |
| Medtronic, INC. | $40.00 | 2023 | Interstim |
| Endo Pharmaceuticals INC. | $29.64 | 2020 | |
| Urovant Sciences INC | $22.00 | 2022 | |
| Axonics, INC. | $21.13 | 2022 | |
| Janssen Biotech, INC. | $18.34 | 2020 | |
| Endo USA, INC. | $17.96 | 2025 | Aveed, Xiaflex |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $12.01 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Desiderio Avila listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.